Related Experiment Videos
Current perspectives on pacing therapy in cardiomyopathies.
S Weiner1, S L Zweibel, J N Gross
1Montefiore Medical Center, Bronx, New York 10467-2401, USA.
Cardiology in Review
|June 1, 1999
Summary
Dual-chamber pacing may offer symptomatic improvement for obstructive hypertrophic cardiomyopathy (HCM), but its effectiveness requires further investigation. Current evidence is mixed, necessitating comprehensive research before widespread recommendation.
Area of Science:
- Cardiology
- Medical Therapy
- Cardiac Pacing
Background:
- Hypertrophic cardiomyopathy (HCM) presents challenges in medical management.
- Surgical interventions for HCM are effective but carry risks.
- Uncontrolled studies suggested dual-chamber pacing benefits obstructive HCM patients symptomatically.
Purpose of the Study:
- To evaluate the symptomatic effects of dual-chamber pacing in obstructive hypertrophic cardiomyopathy.
- To clarify the unclear mechanisms behind pacing's potential benefits in HCM.
- To assess the consistency of pacing therapy benefits in dilated cardiomyopathy.
Main Methods:
- Review of uncontrolled studies on dual-chamber pacing in obstructive HCM.
- Analysis of recent randomized trials assessing pacing effects on HCM symptoms.
- Examination of recent data on pacing therapy for dilated cardiomyopathy.
Main Results:
- Randomized trials show less uniform effects of pacing on HCM symptoms than previously reported.
- The precise mechanism of pacing's effect on HCM remains unclear.
- Initial positive reports on pacing for dilated cardiomyopathy have been only partially confirmed.
Conclusions:
- Further comprehensive research is needed to validate the benefits of pacing therapy in HCM.
- Dual-chamber pacing cannot yet be recommended for widespread use in HCM.
- The efficacy of pacing in dilated cardiomyopathy requires additional investigation.